KEYTRUDA 25 mg/mL concentrate for solution for infusion, Sodium Chloride Intravenous Infusion BP 0.9% w/v clinical trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)

This study looks at a medicine called Keytruda after surgery for kidney cancer to see if it stops the cancer from coming back. It compares Keytruda to a dummy medicine to find out if it's safe and effective.